title: Mood disorders, circadian rhythms, melatonin and melatonin agonists.
abstract: Recent advances in the understanding of circadian rhythms have led to an interest in the treatment of major depressive disorder with chronobiotic agents. Many tissues have autonomous circadian rhythms, which are orchestrated by the master clock, situated in the suprachiasmatic nucleus (SNC). Melatonin (N-acetyl-5-hydroxytryptamine) is secreted from the pineal gland during darkness. Melatonin acts mainly on MT1 and MT2 receptors, which are present in the SNC, regulating physiological and neuroendocrine functions, including circadian entrainment, referred to as the chronobiotic effet. Circadian rhythms has been shown to be either misaligned or phase shifted or decreased in amplitude in both acute episodes and relapse of major depressive disorder (MDD) and bipolar disorder. Manipulation of circadian rhythms either using physical treatments (such as high intensity light) or behavioral therapy has shown promise in improving symptoms. Pharmacotherapy using melatonin and pure melatonin receptor agonists, while improving sleep, has not been shown to improve symptoms of depression. A novel antidepressant, agomelatine, combines 5HT2c antagonist and melatonin agonist action, and has shown promise in both acute treatment of MDD and in preventing relapse.
authors: Sleep Unit, Physiology Department, Hôpital Raymond Poincaré, 104 Boulevard Raymond Poincaré, 92380 Garches, France.
authors: M A
authors: MA
authors: Quera Salva
authors: S
authors: S
authors: Hartley
keywords: agomelatine; circadian rhythms; major depression disorder; melatonin; melatonin agonists
references: J Clin Psychiatry. 2006;67 Suppl 6:9-15
references: 16848671
references: Sleep. 2010 Dec;33(12):1605-14
references: 21120122
references: Am J Ther. 2010 Jan-Feb;17(1):30-3
references: 19417591
references: Prog Neurobiol. 2009 Aug;88(4):264-71
references: 19454302
references: Am J Psychiatry. 1998 Aug;155(8):1119-21
references: 9699707
references: Biochem Pharmacol. 2004 Jun 1;67(11):2023-30
references: 15135299
references: Chronobiol Int. 2010 Jun;27(4):706-21
references: 20560707
references: J Psychiatry Neurosci. 2000 Jan;25(1):48-52
references: 10721684
references: Am J Physiol Regul Integr Comp Physiol. 2002 Jan;282(1):R259-66
references: 11742846
references: Hum Neurobiol. 1982;1(3):195-204
references: 7185792
references: Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R271-7
references: 16987893
references: CNS Drugs. 2009;23 Suppl 2:15-26
references: 19708722
references: Cardiovasc Drugs Ther. 1990 Aug;4(4):1157-60
references: 2083196
references: BMC Emerg Med. 2005 Jul 19;5:5
references: 16029494
references: J Clin Psychiatry. 2010 Feb;71(2):109-20
references: 20193645
references: Reprod Suppl. 2003;61:311-21
references: 14635944
references: Brain Res. 2008 May 13;1209:19-28
references: 18400210
references: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7414-9
references: 16648247
references: Nature. 2005 Mar 31;434(7033):640-4
references: 15800623
references: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1196-201
references: 20600471
references: Int J Neuropsychopharmacol. 2007 Oct;10(5):661-73
references: 17477888
references: Int Clin Psychopharmacol. 2010 Nov;25(6):305-14
references: 20856123
references: Clin Endocrinol (Oxf). 2005 Sep;63(3):298-304
references: 16117817
references: Pharmacol Ther. 2007 May;114(2):222-32
references: 17395264
references: Pharmacol Biochem Behav. 1996 Aug;54(4):713-8
references: 8853194
references: Pharmacol Biochem Behav. 1993 Sep;46(1):45-9
references: 8255922
references: Brain Res. 1979 Oct 5;174(2):245-62
references: 487129
references: Sleep. 1995 Sep;18(7):598-603
references: 8552931
references: J Sleep Res. 2007 Dec;16(4):372-80
references: 18036082
references: Prog Neurobiol. 2008 Jul;85(3):335-53
references: 18571301
references: EMBO Rep. 2001 Apr;2(4):342-6
references: 11306557
references: Life Sci. 1982 Oct 4;31(14):1487-94
references: 7144437
references: Int Clin Psychopharmacol. 2011 Jan;26(1):48-53
references: 20861739
references: Scand J Work Environ Health. 2009 Oct;35(5):361-7
references: 19688143
references: Curr Opin Investig Drugs. 2005 Jan;6(1):114-21
references: 15675611
references: CNS Drugs. 2010 Jun;24(6):479-99
references: 20192279
references: Curr Med Res Opin. 2011 Jan;27(1):87-98
references: 21091391
references: Behav Brain Res. 1996;73(1-2):125-30
references: 8788489
references: Science. 2001 Feb 9;291(5506):1040-3
references: 11232563
references: Hum Psychopharmacol. 2008 Oct;23(7):571-85
references: 18680211
references: J Auton Pharmacol. 1989 Feb;9(1):45-51
references: 2722900
references: FASEB J. 2004 Nov;18(14):1646-56
references: 15522910
references: Neuron. 2010 May 13;66(3):417-28
references: 20471354
references: J Pineal Res. 2011 Aug;51(1):145-55
references: 21517958
references: Drugs Aging. 2009;26(12):997-1012
references: 19929028
references: Curr Psychiatry Rep. 2009 Dec;11(6):488-93
references: 19909672
references: Sleep Med. 2007 Dec;9(1):33-41
references: 17826314
references: J Neurochem. 2010 Jan;112(2):321-31
references: 19860854
references: J Clin Psychol. 2007 May;63(5):463-73
references: 17417811
references: Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):35-8
references: 12898572
references: J Psychopharmacol. 2010 Jan;24(1):111-20
references: 18801825
references: J Clin Psychiatry. 2009 Aug;70(8):1128-37
references: 19689920
references: Psychiatry Res. 1989 Jun;28(3):263-78
references: 2762432
references: J Neuroendocrinol. 2003 Apr;15(4):432-7
references: 12622846
references: Eur Neuropsychopharmacol. 2006 Feb;16(2):93-100
references: 16249073
references: J Clin Sleep Med. 2007 Aug 15;3(5):495-504
references: 17803013
references: Neuropsychiatr Dis Treat. 2009;5:341-54
references: 19557144
references: Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S25-9
references: 16436937
references: Neuropsychiatr Dis Treat. 2008 Feb;4(1):69-79
references: 18728808
references: Am J Psychiatry. 2010 Sep;167(9):1033-7
references: 20826854
references: Brain Res. 1999 Oct 16;845(1):102-6
references: 10529449
references: Pharmacol Ther. 2007 Mar;113(3):507-22
references: 17229466
references: Trends Neurosci. 2003 Jun;26(6):314-20
references: 12798601
references: BMC Med. 2010 Aug 16;8:51
references: 20712869
references: Endocrine. 2005 Jul;27(2):101-10
references: 16217123
references: J Clin Psychiatry. 2005 Oct;66(10):1254-69
references: 16259539
references: Int J Neuropsychopharmacol. 2007 Oct;10(5):691-6
references: 17477886
references: Nat Neurosci. 2010 Sep;13(9):1107-12
references: 20711184
references: Am J Med. 2004 Jan 15;116(2):91-5
references: 14715322
references: Int Clin Psychopharmacol. 2002 Sep;17(5):239-47
references: 12177586
references: Eur J Neurosci. 2009 Feb;29(4):748-60
references: 19200068
references: Neurosci Lett. 2000 Feb 11;280(1):29-32
references: 10696804
references: CNS Spectr. 2005 Aug;10(8):625-34; quiz 1-14
references: 16041294
references: Int Clin Psychopharmacol. 2011 Sep;26(5):252-62
references: 21829106
references: Am J Psychiatry. 2011 Jan;168(1):99-100
references: 21205817
references: J Clin Psychopharmacol. 2009 Jun;29(3):259-66
references: 19440080
references: Dev Neurosci. 2009;31(4):276-84
references: 19546564
references: Biochem Biophys Res Commun. 1999 Sep 7;262(3):832-7
references: 10471411
references: Psychopharmacology (Berl). 1995 Apr;118(4):385-90
references: 7568624
references: Curr Opin Neurobiol. 2011 Dec;21(6):849-57
references: 21737252
references: J Clin Psychiatry. 2007 Nov;68(11):1723-32
references: 18052566
references: Biochem Pharmacol. 2005 Dec 19;71(1-2):74-88
references: 16293234
references: Sleep Med Rev. 2005 Feb;9(1):11-24
references: 15649735
references: Am J Physiol. 1997 Apr;272(4 Pt 2):R1178-88
references: 9140018
references: J Neurochem. 2009 Jul;110(1):231-43
references: 19457131
references: Sleep. 2007 Nov;30(11):1484-501
references: 18041481
references: Psychiatr Prax. 2010 Nov;37(8):405-7
references: 20848378
references: Int Clin Psychopharmacol. 2007 Sep;22(5):283-91
references: 17690597
references: Neuron. 1997 Jul;19(1):91-102
references: 9247266
references: BMJ. 1994 Jul 16;309(6948):167
references: 8044096
references: Psychiatry Res. 2009 Aug 15;168(3):259-61
references: 19524304
references: J Biol Rhythms. 1997 Dec;12(6):636-43
references: 9406039
references: Sleep Med Rev. 2007 Dec;11(6):497-507
references: 17964200
references: Int Clin Psychopharmacol. 2010 May;25(3):132-42
references: 20195158
references: J Child Neurol. 2001 Feb;16(2):139-40
references: 11292222
references: J Clin Psychopharmacol. 2008 Jun;28(3):329-33
references: 18480691
references: Science. 1986 Aug 8;233(4764):667-71
references: 3726555
references: Science. 1998 Feb 27;279(5355):1358-60
references: 9478897
references: Eur J Neurosci. 2009 May;29(9):1820-9
references: 19473235
references: Nat Rev Drug Discov. 2010 Aug;9(8):628-42
references: 20577266
references: J Toxicol Clin Toxicol. 2004;42(3):277-85
references: 15362595
references: J Psychiatr Res. 2001 Nov-Dec;35(6):323-9
references: 11684139
references: Sleep Med. 2003 Sep;4(5):427-33
references: 14592284
references: Psychol Med. 2005 Jul;35(7):939-44
references: 16045060
references: Chronobiol Int. 1992 Oct;9(5):380-92
references: 1394610
references: J Med Chem. 1992 Apr 17;35(8):1484-6
references: 1315395
references: J Biol Rhythms. 2005 Feb;20(1):27-37
references: 15654068
references: BMC Neurosci. 2009 Aug 27;10:105
references: 19712442
references: Pharmacol Rev. 2010 Sep;62(3):343-80
references: 20605968
references: Lancet. 1995 Aug 26;346(8974):541-4
references: 7658780
references: Biol Psychiatry. 2009 Aug 1;66(3):298-301
references: 19358978
references: Pharmacol Ther. 2006 May;110(2):135-370
references: 16522330
references: J Neural Transm Suppl. 1986;21:125-55
references: 2875124